{"id":476831,"date":"2021-03-22T21:00:25","date_gmt":"2021-03-22T14:00:25","guid":{"rendered":"https:\/\/www.vibiznews.com\/?p=476831"},"modified":"2021-03-22T23:21:51","modified_gmt":"2021-03-22T16:21:51","slug":"uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah","status":"publish","type":"post","link":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/","title":{"rendered":"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah"},"content":{"rendered":"<p style=\"text-align: justify;\">(Vibiznews &#8211; Economy &amp; Business) Temuan uji coba besar di AS telah menunjukkan bahwa vaksin virus corona yang dikembangkan oleh AstraZeneca dan Universitas Oxford 79% efektif dalam mencegah gejala penyakit dan 100% efektif melawan penyakit parah dan rawat inap.<\/p>\n<p style=\"text-align: justify;\">Analisis keamanan dan kemanjuran vaksin AstraZeneca, yang diterbitkan Senin, didasarkan pada 32.449 peserta di 88 pusat uji coba di AS, Peru, dan Chili.<\/p>\n<p style=\"text-align: justify;\">Data dari studi percobaan manusia tahap akhir menegaskan kembali bahwa vaksin Oxford-AstraZeneca aman dan sangat efektif.<\/p>\n<p style=\"text-align: justify;\">Sebagai perbandingan, vaksin Moderna ternyata lebih dari 94% efektif dalam mencegah Covid dan vaksin Pfizer-BioNTech ternyata 95% efektif.<\/p>\n<p style=\"text-align: justify;\">AstraZeneca mengatakan akan terus menganalisis data dan mempersiapkan analisis utama untuk dikirimkan ke Badan Pengawas Obat dan Makanan A.S. untuk otorisasi penggunaan darurat dalam beberapa minggu mendatang.<\/p>\n<p style=\"text-align: justify;\">Hasilnya muncul tak lama setelah beberapa negara menghentikan sementara penggunaan suntikan menyusul laporan pembekuan darah pada beberapa orang yang divaksinasi. Pakar kesehatan dengan tajam mengkritik langkah tersebut, dengan alasan kurangnya data, sementara analis menyatakan keprihatinan tentang dampak pada pengambilan vaksin karena virus terus menyebar.<\/p>\n<p style=\"text-align: justify;\">Jerman, Prancis, Italia, dan Spanyol termasuk di antara mereka yang telah melanjutkan penggunaan vaksin Oxford-AstraZeneca setelah regulator obat Eropa mengatakan penyelidikan awal tentang kemungkinan efek samping menyimpulkan bahwa suntikan itu aman dan efektif.<\/p>\n<p style=\"text-align: justify;\">AstraZeneca mengatakan dalam rilisnya hari Senin bahwa dewan independen mengidentifikasi tidak ada masalah keamanan terkait dengan vaksinasi itu. Mereka juga melakukan tinjauan khusus terhadap gumpalan darah serta cerebral venous sinus thrombosis, gumpalan darah yang sangat langka di otak, dengan bantuan ahli saraf independen.<\/p>\n<p style=\"text-align: justify;\">Papan pemantauan keamanan data tidak menemukan peningkatan risiko trombosis atau peristiwa yang ditandai dengan trombosis di antara 21.583 peserta yang menerima setidaknya satu dosis vaksin. Penelusuran khusus untuk CVST tidak menemukan peristiwa dalam uji coba ini.<\/p>\n<p style=\"text-align: justify;\">Saham AstraZeneca diperdagangkan naik 2% selama perdagangan Senin di London.<\/p>\n<p style=\"text-align: justify;\">Di antara peserta dalam analisis sementara, sekitar 20% berusia 65 tahun atau lebih, sementara sekitar 60% memiliki penyakit penyerta yang terkait dengan peningkatan risiko perkembangan Covid yang parah, seperti diabetes atau penyakit jantung.<\/p>\n<pre><em>Asido Situmorang, Senior Analyst, Vibiz Research Center, Vibiz Consulting<\/em><\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(Vibiznews &#8211; Economy &amp; Business) Temuan uji coba besar di AS telah menunjukkan bahwa vaksin virus corona yang dikembangkan oleh AstraZeneca dan Universitas Oxford 79% efektif dalam mencegah gejala penyakit dan 100% efektif melawan penyakit parah dan rawat inap. Analisis keamanan dan kemanjuran vaksin AstraZeneca, yang diterbitkan Senin, didasarkan pada 32.449 peserta di 88 pusat [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":455667,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[29,17],"tags":[],"class_list":["post-476831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economy-business","category-popular_news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com\" \/>\n<meta property=\"og:description\" content=\"(Vibiznews &#8211; Economy &amp; Business) Temuan uji coba besar di AS telah menunjukkan bahwa vaksin virus corona yang dikembangkan oleh AstraZeneca dan Universitas Oxford 79% efektif dalam mencegah gejala penyakit dan 100% efektif melawan penyakit parah dan rawat inap. Analisis keamanan dan kemanjuran vaksin AstraZeneca, yang diterbitkan Senin, didasarkan pada 32.449 peserta di 88 pusat [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/\" \/>\n<meta property=\"og:site_name\" content=\"Vibiznews.com\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-22T14:00:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-22T16:21:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"811\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Asido Situmorang\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asido Situmorang\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/\",\"url\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/\",\"name\":\"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com\",\"isPartOf\":{\"@id\":\"https:\/\/vibiznews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg\",\"datePublished\":\"2021-03-22T14:00:25+00:00\",\"dateModified\":\"2021-03-22T16:21:51+00:00\",\"author\":{\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9\"},\"breadcrumb\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage\",\"url\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg\",\"contentUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg\",\"width\":811,\"height\":608,\"caption\":\"Vibizmedia Photo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vibiznews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vibiznews.com\/#website\",\"url\":\"https:\/\/vibiznews.com\/\",\"name\":\"Vibiznews.com\",\"description\":\"Berita Bisnis | Berita Komoditi | Berita Saham\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vibiznews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9\",\"name\":\"Asido Situmorang\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g\",\"caption\":\"Asido Situmorang\"},\"description\":\"Asido is now the Senior Research Economic of Vibiz Research Center and Editor in Chief of Vibiznews.com, that makes market analysis (fundamental &amp; technical) and research of the economy and business of Indonesia and globally, as well as other related topics such as capital and money market. He also actively writing hundreds of journals, analytical articles and columns in Vibiznews.com.\",\"sameAs\":[\"http:\/\/www.vibiznews.com\"],\"url\":\"https:\/\/vibiznews.com\/index.php\/author\/asido-situmorang\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/","og_locale":"en_US","og_type":"article","og_title":"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com","og_description":"(Vibiznews &#8211; Economy &amp; Business) Temuan uji coba besar di AS telah menunjukkan bahwa vaksin virus corona yang dikembangkan oleh AstraZeneca dan Universitas Oxford 79% efektif dalam mencegah gejala penyakit dan 100% efektif melawan penyakit parah dan rawat inap. Analisis keamanan dan kemanjuran vaksin AstraZeneca, yang diterbitkan Senin, didasarkan pada 32.449 peserta di 88 pusat [&hellip;]","og_url":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/","og_site_name":"Vibiznews.com","article_published_time":"2021-03-22T14:00:25+00:00","article_modified_time":"2021-03-22T16:21:51+00:00","og_image":[{"width":811,"height":608,"url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg","type":"image\/jpeg"}],"author":"Asido Situmorang","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asido Situmorang","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/","url":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/","name":"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah - Vibiznews.com","isPartOf":{"@id":"https:\/\/vibiznews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage"},"image":{"@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage"},"thumbnailUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg","datePublished":"2021-03-22T14:00:25+00:00","dateModified":"2021-03-22T16:21:51+00:00","author":{"@id":"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9"},"breadcrumb":{"@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#primaryimage","url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg","contentUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/10\/amerika.jpg","width":811,"height":608,"caption":"Vibizmedia Photo"},{"@type":"BreadcrumbList","@id":"https:\/\/vibiznews.com\/index.php\/2021\/03\/22\/uji-coba-vaksin-astrazeneca-79-persen-efektif-tidak-ada-risiko-penggumpalan-darah\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vibiznews.com\/"},{"@type":"ListItem","position":2,"name":"Uji Coba Vaksin AstraZeneca 79 Persen Efektif; Tidak Ada Risiko Penggumpalan Darah"}]},{"@type":"WebSite","@id":"https:\/\/vibiznews.com\/#website","url":"https:\/\/vibiznews.com\/","name":"Vibiznews.com","description":"Berita Bisnis | Berita Komoditi | Berita Saham","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vibiznews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/f4e69d2aa33cbc21150bf5f4c57a0ff9","name":"Asido Situmorang","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3b63d42ac4ef6516f2d81883f4324f6c?s=96&d=mm&r=g","caption":"Asido Situmorang"},"description":"Asido is now the Senior Research Economic of Vibiz Research Center and Editor in Chief of Vibiznews.com, that makes market analysis (fundamental &amp; technical) and research of the economy and business of Indonesia and globally, as well as other related topics such as capital and money market. He also actively writing hundreds of journals, analytical articles and columns in Vibiznews.com.","sameAs":["http:\/\/www.vibiznews.com"],"url":"https:\/\/vibiznews.com\/index.php\/author\/asido-situmorang\/"}]}},"_links":{"self":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/476831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/comments?post=476831"}],"version-history":[{"count":1,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/476831\/revisions"}],"predecessor-version":[{"id":476833,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/476831\/revisions\/476833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media\/455667"}],"wp:attachment":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media?parent=476831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/categories?post=476831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/tags?post=476831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}